To determine if the Phoenix sign can be reliably elicited with non-guided subcutaneous infiltration of D5W (5% Dextrose in Water) in patients with subclinical weakness of the extensor hallucis longus (EHL) muscle.
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Changes in motor strength of dorsiflexion of the anterior and lateral compartments of the lower extremity
Timeframe: From enrollment to end of their treatment at 1 day
Presence of absence of increase in motor strength of the lower extremity in dorsiflexion
Timeframe: From enrollment to the end of the day
Number of subjects that have increased dorsiflexion strength after D5W infiltration
Timeframe: Enrollment to end of clinic vist in 1 hour